Doudna and Charpentier won the Nobel Prize in Chemistry for their discovery of the CRISPR-Cas9 technique, a method of ...

A small protein involved in neurodegeneration leading to Parkinson's disease also drives a type of skin cancer known as ...

A tiny protein at the center of Parkinson’s disease also plays a surprising role in melanoma, a dangerous skin cancer. New research reveals that alpha-synuclein, which helps protect brain cells from ...

Colossal has managed to breed after genetically engineering ancient dire wolf DNA into genomes of grey wolves, their closest living relatives.

Could it be that one of only three known markers directly targeting the DNA does not exist outside the realm of microbes? Now ...

The DNA of human cells consists of a sequence of about 3.1 billion building blocks. Cells go to great lengths to maintain the ...

Microbix Biosystems Inc. , a life sciences innovator, manufacturer, and exporter, announces that it will be attending and exhibiting at ESCMID Global 2025 and that a customer and collaborator will be ...

“Colossal–a 10-billion dollar biotechnology company that seeks to combine “the science of genetics with the business of discovery”–has announced the world’s first successfully de-extincted animal, the ...

Colossal’s dire wolf project is not a resurrection – it is an imitation. But that doesn’t mean it lacks value. It offers a ...

A key protein network that keeps cells safe from the dangerous effects of transposable elements has been uncovered.

Colossal Biosciences announces the birth of 3 dire wolf pups, a major breakthrough in de-extinction technology, using ancient DNA and gene editing.